St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Early Detection of Endotheliopathy Post-Transplant
Terminated
- Conditions
- Endotheliopathy
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT05594251
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
Phase 2
Recruiting
- Conditions
- Sickle Cell Disease
- Interventions
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05583721
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies
Phase 2
Terminated
- Conditions
- Myeloid MalignancyHematologic Malignancy
- Interventions
- Drug: Anti-thymocyte globulin (ATG)Radiation: Total Body Irradiation (radiation treatment)Drug: Bone marrow infusion
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 3
- Registration Number
- NCT05579769
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
Not Applicable
Recruiting
- Conditions
- CancerSurvivorshipALLHodgkin Lymphoma
- Interventions
- Device: Transcranial photobiomodulation (tPBM) - Mobile System
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05550948
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Recruiting
- Conditions
- Solid Organ TransplantRespiratory Viral InfectionHematopoietic Cell Transplant
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05550298
- Locations
- 🇺🇸
University of Louisville, Louisville, Kentucky, United States
🇺🇸University of Alabama at Birmingham's (UAB), Birmingham, Alabama, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Phase 2
Recruiting
- Conditions
- Medulloblastoma
- Interventions
- Procedure: Surgical resectionOther: Educational and Media InterventionOther: SOC, Educational and Media InterventionProcedure: Ommaya/VPSRadiation: Irradiation
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05535166
- Locations
- 🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States
🇺🇸Lucille Packard Children's Hospital at Stanford University, Palo Alto, California, United States
🇺🇸Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida, United States
Expanded Access [11C] Methionine PET Imaging
- Conditions
- Central Nervous System TumorHead and Neck Neoplasms
- First Posted Date
- 2022-08-23
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- St. Jude Children's Research Hospital
- Registration Number
- NCT05511714
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
Recruiting
- Conditions
- ALL, AdultCNS TumorSolid Tumor
- Interventions
- Diagnostic Test: CNS Vital Signs (Thinking) TestingOther: Neurocognitive (Thinking) TestingOther: Health Questionnaires, Sleep Surveys & Sleep DiaryDiagnostic Test: Echocardiography/EKGDiagnostic Test: Pulmonary FunctionDevice: Remote PolysomnographyDiagnostic Test: Physical Function
- First Posted Date
- 2022-07-29
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05480904
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Phase 1
Suspended
- Conditions
- Refractory Solid TumorHepatocellular CarcinomaMalignant Solid TumorPediatric CancerPediatric Solid TumorFibrolamellar Carcinoma
- Interventions
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT05468359
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
Recruiting
- Conditions
- Knowledge, Attitudes, Practice
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05454618
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath